Cargando…
Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a polyglutamine expansion in huntingtin. There are no treatments that are known to slow the neurodegeneration caused by this mutation. Mutant huntingtin causes disease via a toxic gain-of-function mechanism a...
Autores principales: | Rose, Claudia, Menzies, Fiona M., Renna, Maurizio, Acevedo-Arozena, Abraham, Corrochano, Silvia, Sadiq, Oana, Brown, Steve D., Rubinsztein, David C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865373/ https://www.ncbi.nlm.nih.gov/pubmed/20190273 http://dx.doi.org/10.1093/hmg/ddq093 |
Ejemplares similares
-
α-Synuclein levels modulate Huntington's disease in mice
por: Corrochano, Silvia, et al.
Publicado: (2012) -
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
por: Underwood, Benjamin R., et al.
Publicado: (2017) -
Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018) -
IGF-1 receptor antagonism inhibits autophagy
por: Renna, Maurizio, et al.
Publicado: (2013) -
Reducing Igf-1r Levels Leads To Paradoxical and Sexually Dimorphic Effects in HD Mice
por: Corrochano, Silvia, et al.
Publicado: (2014)